PCI-Pal revenue growth accelerated in the year to June 2026, with the cloud-based payments security group reporting a 14% rise in revenues to £24.6m and a sharply reduced expected loss of £800,000. The shares jumped 15.9% to 51p.
PCI-Pal Revenue Growth Backed by Recurring Contracts
Annualised recurring revenues rose 29% to £24.4m, according to PCI-Pal’s latest results, providing a forward base that management expects to translate into £27m of revenues in 2026-27. That forecast will be reviewed when full-year figures are published. Net cash stands at £4m.
Recurring revenue represented 93% of total group income in the first half of the financial year, up from 91% in the same period a year earlier, underlining how dependent the business has become on contracted, repeating income.
Two contract wins add momentum. PCI-Pal resecured its HMRC contract on a new eight-year term, announced on 2 July 2026, and confirmed a strategic partnership with NiCE on 30 July 2026, as disclosed via its investor relations pages. The company said the US market remains its most active growth region.
AB Dynamics Cuts Full-Year Revenue Guidance by a Fifth
Automotive testing and simulation supplier AB Dynamics (LON: ABDP) warned that full-year revenues for the year ending 31 August 2026 will come in between £90m and £95m, well short of the consensus figure of £116.7m.
The company said reduced customer confidence and logistics disruption linked to the Middle East have extended decision timelines and hurt near-term order intake. AB Dynamics is also exiting its VadoTech on-road testing operation in China, which accounts for around £4m of previously reported revenues and will be treated as a discontinued operation, according to Yahoo Finance reporting on the announcement. The VadoTech contract is expected to be terminated during the first half of the 2027 financial year.
Management said cost reductions should keep the adjusted operating margin at around 20%. That target looks harder to reach against a backdrop of declining revenues: in the six months ended 28 February 2026, revenue fell 16% to £48.8m, adjusted operating margin ran at 18.6%, and the group posted a statutory operating loss of £12.1m, compared with a statutory operating profit of £6.7m in the same period a year earlier, as shown in the AB Dynamics half-year report.
For context, the group posted full-year revenue of £114.7m and an adjusted operating margin of 20.3% in the year ended 31 August 2025. Net cash at the half-year stage stood at £39.3m. The shares fell 23.9% to 811.5p.
Other Movers on AIM
Oxford BioDynamics (LON: OBD) signed its first commercial agreement for EpiSwitch Orion, a cloud-based 3D genomics platform used in biomarker discovery for psoriatic arthritis. The announcement dated 28 July 2026 confirmed the deal is part of the UK Government-funded OPTIMISE translational research programme. It is the first time a partner has paid for access to the Orion platform, with compensation covering laboratory biomarker discovery and genomic work. The shares gained 12.5% to 0.135p.
Staffing group Empresaria (LON: EMR) expects 2026 pre-tax profit of at least £5.2m after a strong first half, 27% ahead of prior forecasts. Net debt is £17m. The shares recovered 11.1% to 25p.
Fluidpower distributor Flowtech Fluidpower (LON: FLO) reported like-for-like sales growth of 13% in the first half, with overall revenues 24% higher at £70.4m. Full-year pre-tax profit is expected to rise from £1.7m to £4m. The shares advanced 9.32% to 64.5p.
ECR Minerals (LON: ECR) is accelerating development of its Maddens gold project in Queensland through trial alluvial operations at the Brothers mining lease, relocating assets from the Raglan project. The company said there could be around 100,000 cubic metres of minable material. The shares fell 9.76% to 0.185p.
Premier African Minerals (LON: PREM) said it will not start plant operations at the Zulu lithium and tantalum project in July. Talks continue with Canmax over extending the long stop date for prepayment and offtake arrangements. The shares fell 7.89% to 0.0175p.
Niox Group (LON: NIOX) reported a 4% fall in interim revenues to £24m, with EBITDA down from £9.2m to £8.3m. Regulatory approvals for NIOX PRO are expected in the US and Japan later in 2026. Net cash was £16.8m at end of June 2026. The shares slipped 4.95% to 61.4p.
For AB Dynamics, the key test is whether the adjusted operating margin holds at 20% once a full revenue picture for the year ended 31 August 2026 is published.
